학술논문
Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis
Document Type
Correspondence
Author
Source
In Blood Advances 27 September 2022 6(18):5436-5439
Subject
Language
ISSN
2473-9529